Genetic variants associated with VLDL, LDL and HDL particle size differ with race/ethnicity

Human Genetics

Volumn 132, Issue 4, 2013, Pages 405-413

  Frazier Wood, Alexis C ^a,b   Manichaikul, Ani ^c,d   Aslibekyan, Stella ^a   Borecki, Ingrid B ^e   Goff, David C ^f   Hopkins, Paul N ^g   Lai, Chao Qiang ^h   Ordovas, Jose M ^h,i,j   Post, Wendy S ^k,l   Rich, Stephen S ^d   Sale, Michèle M ^d   Siscovick, David ^m   Straka, Robert J ⁿ   Tiwari, Hemant K ^a   Tsai, Michael Y ^o   Rotter, Jerome I ^p   Arnett, Donna K ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f Global Health and Health Disparities   (United States)

^g UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^h TUFTS UNIVERSITY   (United States)

ⁱ CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^j IMDEA FOOD INSTITUTE   (Spain)

^k JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^m UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

ⁿ UNIVERSITY OF MINNESOTA   (United States)

^o UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^p CEDARS SINAI MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; ATHEROSCLEROSIS; CAUCASIAN; CHINESE; ETHNICITY; FEMALE; GENE LOCUS; GENE REPLICATION; GENETIC VARIABILITY; GENOME ANALYSIS; GENOTYPE; HISPANIC; HUMAN; MALE; PARTICLE SIZE; PEDIGREE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; RACE DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AFRICAN AMERICANS; AGED; ASIAN AMERICANS; ATHEROSCLEROSIS; FEMALE; HISPANIC AMERICANS; HUMANS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; MALE; MIDDLE AGED; MODELS, GENETIC; PARTICLE SIZE; PEDIGREE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84876492212     PISSN: 03406717     EISSN: 14321203     Source Type: Journal    
DOI: 10.1007/s00439-012-1256-1     Document Type: Article

References (38)

1. Aouizerat BE, Kulkarni M, Heilbron D, Drown D, Raskin S, Pullinger CR, Malloy MJ et al (2003) Genetic analysis of a polymorphism in the human apoA-V gene: effect on plasma lipids. J Lipid Res 44(6):1167-1173
2. Atkinson B, Thereau T (2007) Kinship: mixed-effects Cox models, sparse matrices, and modeling data from large pedigrees. R package version, 1(1.0-17)
3. Austin MA, Talmud PJ, Luong LA, Haddad L, Day IN, Newman B, Edwards KL et al (1998) Candidate-gene studies of the atherogenic lipoprotein phenotype: a sib-pair linkage analysis of DZ women twins. Am J Human Genetics 62(2):406-419
4. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics (Oxford, England) 21(2):263-265
5. Beard CM, Barnard RJ, Robbins DC, Ordovas JM, Schaefer EJ (1996) Effects of diet and exercise on qualitative and quantitative measures of LDL and its susceptibility to oxidation. Arterioscler Thromb Vasc Biol 16(2):201-207
6. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc Ser B (Methodol) 57(1):289-300
7. Bild DE (2002) Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 156(9):871-881
8. Chasman DI, Paré G, Mora S, Hopewell JC, Peloso G, Clarke R, Cupples LA et al. (2009) Forty-three loci associated with plasma lipoprotein size, concentration, and cholesterol content in genome-wide analysis. (GR. Abecasis, Ed.) PLoS Genet, 5(11):e1000730
9. Couture P, Otvos JD, Cupples LA, Lahoz C, Wilson PWF, Schaefer EJ, Ordovas JM (2000) Association of the C-514T polymorphism in the hepatic lipase gene with variations in lipoprotein subclass profiles: the Framingham offspring study. Arterioscler Thromb Vasc Biol 20(3):815-822
10. Festa A, Williams K, Hanley AJ, Otvos JD, Goff DC, Wagenknecht LE, Haffner SM (2005) Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the insulin resistance atherosclerosis study. Circulation, 111:3465-3472. Department of Medicine, University of Texas Health Science Center, San Antonio, TX 78229-3900, USA
11. Frazier-Wood AC, Aslibekyan S, Borecki IB, Hopkins PN, Lai CQ, Ordovas JM, Straka RJ et al (2012) Genome-wide association study indicates variants associated with insulin signaling and inflammation mediate lipoprotein responses to fenofibrate. Pharmacogenet Genomics 22(10):750-757
12. Freeman D (2003) A polymorphism of the cholesteryl ester transfer protein gene predicts cardiovascular events in non-smokers in the West of Scotland coronary prevention study. Eur Heart J 24(20):1833-1842
13. Garvey WT, Kwon S, Zheng D, Shaughnessy S, Wallace P, Hutto A, Pugh K et al (2003) Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. Diabetes 52:453-462
14. Goff DC Jr, D'Agostino RB Jr, Haffner SM, Otvos JD (2005) Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the insulin resistance atherosclerosis study. Metabolism 54:264-270
15. Goodarzi MO, Guo X, Taylor KD, Quiñones MJ, Samayoa C, Yang H, Saad MF et al (2003) Determination and use of haplotypes: ethnic comparison and association of the lipoprotein lipase gene and coronary artery disease in Mexican-Americans. Genet Med 5(4):322-327
16. Gray RS, Robbins DC, Wang W, Yeh JL, Fabsitz RR, Cowan LD, Welty TK et al (1997) Relation of LDL size to the insulin resistance syndrome and coronary heart disease in American Indians. The Strong Heart Study. Arterioscler Thromb Vasc Biol 17:2713-2720
17. Jeyarajah EJ, Cromwell WC, Otvos JD (2006) Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy. Clin Lab Med 26(4):847-870
18. Kabagambe EK, Ordovas JM, Tsai MY, Borecki IB, Hopkins PN, Glasser SP, Arnett DK (2009) Smoking, inflammatory patterns and postprandial hypertriglyceridemia. Atherosclerosis 203:633-639
19. Korn JM, Kuruvilla FG, McCarroll SA, Wysoker A, Nemesh J, Cawley S, Hubbell E et al (2008) Integrated genotype calling and association analysis of SNPs, common copy number polymorphisms and rare CNVs. Nat Genet 40(10):1253-1260
20. Kral BG, Becker LC, Yook RM, Blumenthal RS, Kwiterovich PO, Otvos JD, Becker DM (2001) Racial differences in low-density lipoprotein particle size in families at high risk for premature coronary heart disease. Ethn Dis 11(2):325-337
21. Kullo IJ, Jan MF, Bailey KR, Mosley TH, Turner ST (2007) Ethnic differences in low-density lipoprotein particle size in hypertensive adults. J Clin Lipidol 1(3):218-224
22. Lemieux I, Laperrière L, Dzavik V, Tremblay G, Bourgeois J, Després J-P (2002) A 16-week fenofibrate treatment increases LDL particle size in type IIA dyslipidemic patients. Atherosclerosis 162(2):363-371
23. Manichaikul A, Mychaleckyj JC, Rich SS, Daly K, Sale M, Chen W-M (2010) Robust relationship inference in genome-wide association studies. Bioinformatics (Oxford, England) 26(22):2867-2873
24. Melenovsky V, Malik J, Wichterle D, Simek J, Pisarikova A, Skrha J, Poledne R et al (2002) Comparison of the effects of atorvastatin or fenofibrate on nonlipid biochemical risk factors and the LDL particle size in subjects with combined hyperlipidemia. Am Heart J 144(4):E11-E18
25. Nature Publishing Group (2012) Asking for more. Nature Genet 44(7):733
26. Nettleton JA, Steffen LM, Ballantyne CM, Boerwinkle E, Folsom AR (2007) Associations between HDL-cholesterol and polymorphisms in hepatic lipase and lipoprotein lipase genes are modified by dietary fat intake in African American and White adults. Atherosclerosis 194(2):e131-e140
27. Nishina PM, Johnson JP, Naggert JK, Krauss RM (1992) Linkage of atherogenic lipoprotein phenotype to the low density lipoprotein receptor locus on the short arm of chromosome 19. Proc Natl Acad Sci USA 89:0027-8424
28. O'Meara JG, Kardia SLR, Armon JJ, Brown CA, Boerwinkle E, Turner ST (2004) Ethnic and sex differences in the prevalence, treatment, and control of dyslipidemia among hypertensive adults in the GENOA study. Arch Intern Med 164(12):1313-1318
29. Okumura K, Matsui H, Ogawa Y, Takahashi R, Matsubara K, Imai H, Imamura A et al (2003) The polymorphism of the beta3-adrenergic receptor gene is associated with reduced low-density lipoprotein particle size. Metabolism 52:356-361
30. Osgood D (2003) Genetic variation at the scavenger receptor class B type I gene locus determines plasma lipoprotein concentrations and particle size and interacts with type 2 diabetes: the Framingham study. J Clin Endocrinol Metab 88:2869-2879
31. Rotter JI, Bu X, Cantor RM, Warden CH, Brown J, Gray RJ, Blanche PJ et al (1996) Multilocus genetic determinants of LDL particle size in coronary artery disease families. Am J Hum Genet 58:585-594
32. Ruel IL, Gaudet D, Perron P, Bergeron J, Julien P, Lamarche B (2002) Characterization of LDL particle size among carriers of a defective or a null mutation in the lipoprotein lipase gene: the Quebec LIPD Study. Arterioscler Thromb Vasc Biol 22:1181-1186
33. Storey JD, Tibshirani R (2003) Statistical significance for genomewide studies. Proc Natl Acad Sci USA 100(16):9440-9445
34. Talmud PJ, Edwards KL, Turner CM, Newman B, Jutta M, Humphries SE, Austin MA et al (2000) Linkage of the cholesteryl ester transfer protein (CETP) gene to LDL particle size. Use of a novel tetranucleotide repeat within the CETP promoter. Circulation 101:2461-2466
35. Talmud PJ, Martin S, Taskinen M-R, Frick MH, Nieminen MS, Kesäniemi YA, Pasternack A et al (2004) APOA5 gene variants, lipoprotein particle distribution, and progression of coronary heart disease: results from the LOCAT study. J Lipid Res 45(4):750-756
36. Wang J, Qiang H, Chen D, Zhang C, Zhuang Y (2002) CETP gene mutation (D442G) increases low-density lipoprotein particle size in patients with coronary heart disease. Clin Chim Acta 322:85-90
37. Wood RJ, Volek JS, Liu Y, Shachter NS, Contois JH, Fernandez ML (2006) Carbohydrate restriction alters lipoprotein metabolism by modifying VLDL, LDL, and HDL subfraction distribution and size in overweight men. J Nutr 136(2):384-389
38. Wung S-F, Aouizerat BE (2003) Gender and ethnic differences in a case-control study of dyslipidemia: using the apolipoprotein A-V gene as an exemplar in cardiovascular genetics. Res Theory Nurs Pract 17(4):281-299